Advertisement
Screener

Instil Bio, Inc. (TIL) Basic Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

Instil Bio, Inc. Basic Shares Outstanding (Weighted Average)

Instil Bio, Inc. (TIL) reported Basic Shares Outstanding (Weighted Average) of 6.78 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13

  • Instil Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 6.78M shares, a 2.80% increase year-over-year.
  • Instil Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 6.78M shares, a 3.82% increase year-over-year.
  • Instil Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 6.78M shares, a 3.94% increase year-over-year.
  • Instil Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 6.76M shares, a 3.86% increase year-over-year.
  • Instil Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 6.67M shares, a 2.43% increase from fiscal 2024.
  • Instil Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 6.51M shares, a 0.10% increase from fiscal 2023.
  • Instil Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 6.50M shares, a 0.44% increase from fiscal 2022.
  • Instil Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 6.48M shares, a 93.89% decline from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 3 month as first filedWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 6 month as first filedWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 9 month as first filedWeighted Average Number of Shares Outstanding, Basic 12 monthWeighted Average Number of Shares Outstanding, Basic 12 month as first filed
2026-06-306.78M shares
10-Q · filed 2026-08-13
6.78M shares
10-Q · filed 2026-08-13
6.78M shares
derived: average of 3 quarters · filed 2026-08-13
6.78M shares
derived: average of 4 quarters · filed 2026-08-13
2026-03-316.78M shares
10-Q · filed 2026-05-15
6.78M shares
derived: average of 2 quarters · filed 2026-05-15
6.77M shares
derived: average of 3 quarters · filed 2026-05-15
6.73M shares
derived: average of 4 quarters · filed 2026-08-13
2025-12-316.78M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
6.77M shares
derived: average of 2 quarters · filed 2026-03-27
6.71M shares
derived: average of 3 quarters · filed 2026-08-13
6.67M shares
10-K · filed 2026-03-27
2025-09-306.76M shares
10-Q · filed 2025-11-13
6.68M shares
derived: average of 2 quarters · filed 2026-08-13
6.63M shares
10-Q · filed 2025-11-13
6.60M shares
derived: average of 4 quarters · filed 2026-08-13
2025-06-306.60M shares
10-Q · filed 2026-08-13
6.56M shares
10-Q · filed 2026-08-13
6.55M shares
derived: average of 3 quarters · filed 2026-08-13
6.54M shares
derived: average of 4 quarters · filed 2026-08-13
2025-03-316.53M shares
10-Q · filed 2026-05-15
6.53M shares
derived: average of 2 quarters · filed 2026-05-15
6.52M shares
derived: average of 3 quarters · filed 2026-05-15
6.52M shares
derived: average of 4 quarters · filed 2026-05-15
2024-12-316.53M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
6.52M shares
derived: average of 2 quarters · filed 2026-03-27
6.51M shares
derived: average of 3 quarters · filed 2026-03-27
6.51M shares
10-K · filed 2026-03-27
2024-09-306.51M shares
10-Q · filed 2025-11-13
6.51M shares
derived: average of 2 quarters · filed 2025-11-13
6.50M shares
10-Q · filed 2025-11-13
6.50M shares
derived: average of 4 quarters · filed 2025-11-13
2024-06-306.50M shares
10-Q · filed 2025-08-13
6.50M shares
10-Q · filed 2025-08-13
6.50M shares
derived: average of 3 quarters · filed 2025-08-13
6.50M shares
derived: average of 4 quarters · filed 2025-08-13
2024-03-316.50M shares
10-Q · filed 2025-05-13
6.50M shares
derived: average of 2 quarters · filed 2025-05-13
6.50M shares
derived: average of 3 quarters · filed 2025-05-13
6.50M shares
derived: average of 4 quarters · filed 2025-05-13
2023-12-316.50M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04
6.50M shares
derived: average of 2 quarters · filed 2025-03-04
6.50M shares
derived: average of 3 quarters · filed 2025-03-04
6.50M shares
10-K · filed 2025-03-04
2023-09-306.50M shares
10-Q · filed 2024-11-13
130.08M shares
10-Q · filed 2023-11-13
6.50M shares
derived: average of 2 quarters · filed 2024-11-13
6.50M shares
10-Q · filed 2024-11-13
130.08M shares
10-Q · filed 2023-11-13
-85.69M shares
derived: average of 4 quarters · filed 2024-11-13
2023-06-306.50M shares
10-Q · filed 2024-08-13
130.08M shares
10-Q · filed 2023-08-14
6.50M shares
10-Q · filed 2024-08-13
130.08M shares
10-Q · filed 2023-08-14
-116.42M shares
derived: average of 3 quarters · filed 2024-08-13
-54.90M shares
derived: average of 4 quarters · filed 2024-08-13
2023-03-316.50M shares
10-Q · filed 2024-05-10
130.08M shares
10-Q · filed 2023-05-11
-177.88M shares
derived: average of 2 quarters · filed 2024-05-10
-75.36M shares
derived: average of 3 quarters · filed 2024-05-10
-24.18M shares
derived: average of 4 quarters · filed 2024-05-10
2022-12-31-362.27M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
-116.30M shares
derived: average of 2 quarters · filed 2024-03-21
-34.41M shares
derived: average of 3 quarters · filed 2024-03-21
6.48M shares
10-K · filed 2024-03-21
129.51M shares
10-K · filed 2023-03-31
2022-09-30129.68M shares
10-Q · filed 2023-11-13
129.52M shares
derived: average of 2 quarters · filed 2023-11-13
129.39M shares
10-Q · filed 2023-11-13
129.34M shares
derived: average of 4 quarters · filed 2023-11-13
2022-06-30129.37M shares
10-Q · filed 2023-08-14
129.24M shares
10-Q · filed 2023-08-14
129.23M shares
derived: average of 3 quarters · filed 2023-08-14
129.12M shares
derived: average of 4 quarters · filed 2023-08-14
2022-03-31129.12M shares
10-Q · filed 2023-05-11
129.16M shares
derived: average of 2 quarters · filed 2023-05-11
129.04M shares
derived: average of 3 quarters · filed 2023-05-11
128.97M shares
derived: average of 4 quarters · filed 2023-05-11
2021-12-31129.20M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
129.00M shares
derived: average of 2 quarters · filed 2023-03-31
128.91M shares
derived: average of 3 quarters · filed 2023-03-31
105.99M shares
10-K · filed 2023-03-31
2021-09-30128.79M shares
10-Q · filed 2022-11-14
128.77M shares
derived: average of 2 quarters · filed 2022-11-14
98.26M shares
10-Q · filed 2022-11-14
77.41M shares
derived: average of 4 quarters · filed 2022-11-14
2021-06-30128.74M shares
10-Q · filed 2022-08-12
82.48M shares
10-Q · filed 2022-08-12
60.29M shares
derived: average of 3 quarters · filed 2022-08-12
49.45M shares
derived: average of 4 quarters · filed 2022-08-12
2021-03-3134.98M shares
10-Q · filed 2022-05-16
26.06M shares
derived: average of 2 quarters · filed 2022-05-16
23.02M shares
derived: average of 3 quarters · filed 2022-05-16
21.47M shares
derived: average of 4 quarters · filed 2022-05-16
2020-12-3117.14M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07
17.04M shares
derived: average of 2 quarters · filed 2022-03-07
16.97M shares
derived: average of 3 quarters · filed 2022-03-07
16.00M shares
10-K · filed 2022-03-07
2020-09-3016.93M shares
10-Q · filed 2021-11-15
16.89M shares
derived: average of 2 quarters · filed 2021-11-15
15.62M shares
10-Q · filed 2021-11-15
2020-06-3016.85M shares
10-Q · filed 2021-08-12
14.94M shares
10-Q · filed 2021-08-12
2020-03-3113.00M shares
10-Q · filed 2021-05-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tevogen Inc. (TVGN)United States$0.049B
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
Scilex Holding Co (SCLX)United States$0.042B-0.14
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioAtla, Inc. (BCAB)United States$0.058B-0.21
EXOZYMES INC. (EXOZ)United States$0.058B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
aTYR PHARMA INC (ATYR)United States$0.033B-0.98